A kind of anisodamine hydrobromide and its preparation method and quality control method

Preparation of anisopolamine hydrobromide by yogurt extract enzyme method, solving the problem of high synthesis process cost and inappropriate single configuration in the prior art, and achieving high purity and high yield of anisopolamine hydrobromide Preparation, suitable for industrial production, and quality control by high performance liquid chromatography.

CN115572291BActive Publication Date: 2024-11-22CHENGDU FIRST PHARMACEDTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211192647.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-28
Publication Date
2024-11-22
Estimated Expiration
2042-09-28

AI Technical Summary

Technical Problem

The existing synthesis process of anisolamine hydrobromide has problems such as high cost, high technical difficulty and inappropriate for single configuration preparation. The existing methods mainly obtain racemic products through chiral separation, which is difficult to industrialize.

Method used

The ester-dissolving of tropic acid by enzymatic esterization was obtained by synthesis of a single configuration of anisopylate under the action of a catalyst, and the reaction of L-tropic acid and 6-methoxymethoxytropic alcohol was carried out. , combined with hydrochloric acid hydrolysis and hydrobromic acid crystallization, the preparation of anisolamine hydrobromic acid is realized, and a quality control method is provided by high-performance liquid chromatography.

Benefits of technology

It significantly improves the product purity and yield of anisolamine hydrobromide, simplifies the process flow, is suitable for industrial production, and ensures the single configuration and efficient production of the product through quality control methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115572291B_ABST
    Figure CN115572291B_ABST
Patent Text Reader

Abstract

The invention discloses anisodamine hydrobromide and a preparation method and quality control method thereof. The preparation method of anisodamine hydrobromide of the invention uses a datura flower extract containing a large amount of tropane alkaloids as a starting material, obtains a single-configuration tropic acid by enzymatic esterification, and then directs the synthesis of a single-configuration anisodamine under the action of a catalyst. The process is relatively simple, the chiral separation link is reduced, and the yield and purity of anisodamine hydrobromide are significantly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of pharmaceutical chemical industry, and specifically relates to anisodamine hydrobromide and a preparation method and a quality control method thereof. Background Art

[0002] Anisodamine is an alkaloid extracted from the Solanaceae plant, which is a specialty of my country. It was first used in clinical practice in April 1965 and is referred to as 654. 654 has been widely used in serious infectious diseases such as toxic dysentery, fulminant epidemic meningitis, and lobar pneumonia, reducing the mortality rate of fulminant epidemic meningitis from 66.9% to 12.4%. Due to the large amount of clinical use, in order to reduce costs and ensure supply, "racemic anisodamine" was artificially synthesized later, called 654-2, and the two have different structures. 654-1 is a single configuration (6S, 2S), has the best binding degree with M receptors, and has a stronger analgesic effect on smooth muscle than 654-2; 654-2 is composed of four optical isomers, and has stronger effects on pupil dilation and inhibition of saliva secretion than 654-1. In toxicological experiments, the median lethal dose (LD50) of 654-2 is slightly larger than that of 654-1.

[0003] There are few reports on the synthesis process of 654-1 anisodamine hydrobromide. In actual production, racemic anisodamine is mainly synthesized, and then chiral separation is performed to obtain a single-configuration anisodamine hydrobromide. Chiral separation generally uses chiral column chromatography, capillary electrophoresis, chiral reagents, etc., which has the disadvantages of high cost, great technical difficulty, and some technologies are difficult to industrialize.

[0004] The prior art discloses a method for synthesizing anisodamine, the main raw material of anisodamine hydrobromide (Zheng Changsheng, A New Synthesis Method for Racemic Anisodamine [J], Chinese Journal of Pharmaceutical Industry Impurities, 1989, 20(3)). Since racemic anisodamine is obtained, when it is used to prepare anisodamine hydrobromide, racemic anisodamine hydrobromide is also obtained. The synthesis process is also not suitable for the preparation of anisodamine hydrobromide of a single configuration. Summary of the invention

[0005] In order to solve the above technical problems, the object of the present invention is to provide a method for preparing anisodamine hydrobromide according to the existing synthesis process, which comprises the following steps:

[0006] a Preparation of L-tropic acid: Take a datura flower extract, add water and ES-PLE-101 type lipase to hydrolyze, then add an organic solvent to extract, remove the organic solvent from the extract, add acid water to adjust the pH to acidic, and crystallize to obtain L-tropic acid;

[0007] b. Preparation of 6-methoxymethoxy tropinol: 6-hydroxy tropinone and dimethoxymethane are mixed and reacted, the obtained reactant is cooled to below 10°C, sodium carbonate solution is added until the pH is alkaline, the organic phase is removed from the organic solvent, 95% ethanol is added to dissolve, a catalyst is added, hydrogen is passed through for hydrogenation, and 6-methoxymethoxy tropinol is obtained by filtration and concentration;

[0008] c. Preparation of scopolamine hydrobromide: 6-methoxymethoxy tropane obtained in step b and L-tropic acid obtained in step a are mixed, a catalyst is added to react, the reactant is hydrolyzed by adding hydrochloric acid, the pH of the hydrolyzate is adjusted to alkaline, an organic solvent is added for extraction, and the extract is concentrated to obtain a crude anisodamine product, the crude anisodamine product is dissolved in anhydrous ethanol, and hydrobromic acid is added to pH 2 to 4, crystallized, filtered, and the crystals are recrystallized to obtain.

[0009] Furthermore, the mass volume ratio of the datura flower extract, water, ES-PLE-101 type lipase and organic solvent in step a is 1000g:5000-40000ml:0.1-10g:5000-40000ml.

[0010] Furthermore, the organic solvent is dichloromethane, chloroform or ethyl acetate, preferably dichloromethane.

[0011] Furthermore, in step a, the acid water is a 5% sulfuric acid solution; the pH is adjusted to 3-4; and the crystallization temperature is 5°C.

[0012] Furthermore, in step b, the mass ratio of the 6-hydroxytropinone to the dimethoxymethane is 1:0.5-2; the reaction conditions are: p-toluenesulfonic acid as a catalyst, dichloromethane as a reaction solvent, and reflux reaction at 30-60° C. for 12-36 hours;

[0013] Said adding catalyst Raney nickel;

[0014] The mixture was passed with hydrogen to 204 KPa and shaken at room temperature for 8 h.

[0015] Furthermore, in step c, the mass ratio of the 6-methoxymethoxy tropine alcohol to the L-tropine acid is 1:0.8-1.6; the catalyst is an acidic strong cation exchange resin; the reaction conditions are acetone as a solvent, and the reaction is carried out at 40-60° C. for 4-8 hours;

[0016] The hydrolysis temperature is 60-80°C, and the time is 4-8 hours; the concentration of the hydrochloric acid is 5%, v / v, and the amount used is 2-3 times the sum of the 6-methoxymethoxytropine alcohol and the L-tropine acid, ml / g;

[0017] The pH of the hydrolyzate is adjusted to 9.0-10.0;

[0018] The organic solvent is dichloromethane, and the amount used is 1 times the amount of the hydrolyzate, ml / ml;

[0019] The mass volume ratio of the crude anisodamine to anhydrous ethanol is 1-2 g:1-5 ml; the concentration of the hydrobromic acid is 10%, v / v.

[0020] Furthermore, the datura flower extract is an ethanol extract of datura flower dissolved in 5% sulfuric acid, filtered to remove insoluble matter, and then concentrated to obtain a thick paste with a relative density of 1.8 to 2.4.

[0021] The invention also provides anisodamine hydrobromide, which is prepared according to the above method.

[0022] The present invention also provides a quality control method for the aforementioned anisodamine hydrobromide sterilization process, comprising the following steps:

[0023] S1. Take the aforementioned anisodamine hydrobromide, add water to make a solution, sterilize at 100 to 150° C. for 10 to 15 minutes to obtain a sterilized anisodamine hydrobromide solution; remove the anisodamine reference substance, and add water to make a reference substance solution;

[0024] S2. The anisodamine hydrobromide solution and the reference substance solution obtained in step S1 are detected by high performance liquid chromatography, and the chromatographic conditions of the high performance liquid chromatography are:

[0025] Octadecylsilane bonded silica gel is used as filler;

[0026] Acetonitrile-50mmol / L dipotassium hydrogen phosphate in a volume ratio of 10:90 was used as mobile phase A; acetonitrile-50mmol / L dipotassium hydrogen phosphate in a volume ratio of 45:55 was used as mobile phase B;

[0027] The elution gradient is:

[0028]

[0029] The column temperature was 30°C; the detection wavelength was 210 nm;

[0030] The injection volume was 20 μl and the flow rate was 1.0 ml / min;

[0031] S3. Compare the chromatogram of the anisodamine hydrobromide solution described in step S2 with the chromatogram of the reference solution, and present a chromatographic peak in the chromatogram of the anisodamine hydrobromide solution with a retention time consistent with that of the isomer in the chromatogram of the reference solution, to determine that the anisodamine hydrobromide solution contains isomers, and the generation rate of the isomers is calculated as the ratio of the peak area of ​​the isomer in the chromatogram of the anisodamine hydrobromide solution to the sum of the areas of all chromatographic peaks.

[0032] Furthermore, in step S1, the water is water for injection; the sterilization temperature is 121° C., and the time is 15 min.

[0033] Furthermore, in step S1, the pH of the 50 mmol / L dipotassium hydrogen phosphate is adjusted to 6.0 using phosphoric acid.

[0034] The preparation method of scopolamine hydrobromide of the present invention uses a datura flower extract containing a large amount of tropane alkaloids as a starting material, obtains single-configuration tropic acid through enzymatic esterification, and then directionally synthesizes single-configuration scopolamine under the action of a catalyst. The process is relatively simple, the chiral separation link is reduced, and the product yield and purity are significantly improved.

[0035] Tests have confirmed that the anisodamine hydrobromide product produced by the preparation method of anisodamine hydrobromide of the present invention has a purity of up to 99%, a yield of more than 50%, and is anisodamine hydrobromide of a single configuration. The anisodamine hydrobromide obtained by the preparation method of the present invention has various indicators that are superior to those of the products obtained in the prior art, and the method of the present invention is simple to operate and suitable for industrial production.

[0036] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.

[0037] The following is a further detailed description of the above contents of the present invention through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies implemented based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 Chromatogram of Anisodamine Hydrobromide Injection (Batch No. 21122901-B);

[0039] Figure 2 Chromatogram of racemic anisodamine.

[0040] Figure 3 Molecular mass MS full spectrum

[0041] Figure 4 1 H-NMR spectrum

[0042] Figure 5 13 C-NMR spectrum

[0043] Figure 6 Molecular structure (C1 is S configuration, C2 is R configuration, C4 is S configuration, C6 is R configuration, C10 is R configuration)

[0044] Figure 7 Chromatogram of injection solution made from commercially available raw materials

[0045] Figure 8 Example 1 Chromatogram of injection prepared from anisodamine hydrobromide DETAILED DESCRIPTION

[0046] Example 1 Preparation of Anisodamine Hydrobromide

[0047] Step 1: 200 kg of datura flower is extracted with 4000 L of ethanol, concentrated under reduced pressure at 65°C to remove ethanol, 10 L of 5% sulfuric acid is added to dissolve, and the mixture is allowed to stand at 15°C and precipitated in water, insoluble matter is filtered out, and concentrated under reduced pressure at 75°C to a paste (relative density: 1.8-2.4) to obtain 1.06 kg of datura flower extract.

[0048] Step 2: Take 1.06 kg of datura flower extract, add 10 L of water to dissolve, then add 100 g of ES-PLE-101 lipase (23 U / mg), stir and mix, hydrolyze at 40 ° C for 2 h, extract with dichloromethane 5 times, each time with 10 L of dichloromethane, distill and concentrate the extract to remove dichloromethane to obtain a crude L-tropic acid paste; the crude paste is dissolved with 5% sulfuric acid solution (control pH 3-4), and crystallized at 5 ° C to obtain 640 g of L-tropic acid.

[0049] Step 3, 500g of 6-hydroxytropinone was dissolved in 1.5L of dichloromethane. 300g of dimethoxymethane was added, mixed evenly, 100g of p-toluenesulfonic acid was added, and the reaction was carried out at 50°C for 24 hours. After the reaction, the solution was cooled to below 10°C, and sodium carbonate solution was added dropwise until the solution was alkaline. The organic phase was separated and the organic solvent was removed by vacuum distillation to obtain 452g of 6-methoxymethoxytropinone. 6-methoxymethoxytropinone was dissolved in 95% ethanol, 30g of Raney nickel was added as a catalyst, hydrogen was charged to 204Kpa, and the mixture was shaken at room temperature for 8h, filtered, and the filtrate was concentrated to obtain 448g of 6-methoxymethoxytropinol.

[0050] Step 4: esterification reaction (80°C, 4h) of 448g 6-methoxymethoxytropine alcohol and 540g L-tropic acid in 120g acidic strong cation exchange resin as catalyst and 100ml acetone as solvent. After the reaction, the mixture was hydrolyzed in 2560ml 5% hydrochloric acid solution for 6 hours to obtain anisodamine hydrochloric acid solution. The anisodamine hydrochloric acid solution was adjusted to pH 9.0-10.0, and extracted 4 times with 1-fold amount of dichloromethane to obtain anisodamine extract. The anisodamine extract was concentrated under reduced pressure at 65°C to obtain 1.2 kg of crude anisodamine, which was dissolved in 2.5 L of anhydrous ethanol, and 40% hydrobromic acid solution (650 ml) was added dropwise to pH 2-4, and crystallized at 5-10°C for 12 hours, filtered, and the filter cake was dried at 80°C to obtain 1.05 kg of crude anisodamine hydrobromide. 1.05 kg of crude anisodamine hydrobromide was added to 6 L of anhydrous ethanol and dissolved under reflux at 75°C, crystallized in the same way (i.e., adding hydrobromic acid to pH 2-4, crystallizing at 5-10°C for 12 hours), dried and crushed to obtain 805 g of anisodamine hydrobromide. The yield based on 6-hydroxytropinone was 64.5%, and the chromatographic purity was 99.8%.

[0051] Example 2: Preparation of Anisodamine Hydrobromide

[0052] Step 1: 200 kg of datura flower is extracted with 4000 L of ethanol, concentrated under reduced pressure at 60-80°C to remove ethanol, 10 L of 5% sulfuric acid is added to dissolve, and the mixture is allowed to stand at 10-30°C and precipitated in water, insoluble matter is filtered out, and concentrated under reduced pressure at 70-90°C to a paste (relative density: 1.8-2.4) to obtain 1.02 kg of datura flower extract.

[0053] Step 2: Take 1.02 kg of datura flower extract, add 10 L of water to dissolve, add 100 g of ES-PLE-126 lipase (23 U / mg), stir and mix, hydrolyze at 40 ° C for 2 h, extract with dichloromethane 4 to 6 times, each time with 10 L of dichloromethane, distill and concentrate the extract to remove dichloromethane to obtain a crude L-tropic acid paste; dissolve the crude paste with 5% sulfuric acid solution (control pH 3-4), crystallize at 2 to 10 ° C to obtain 620 g of L-tropic acid.

[0054] Step 3, 500g of 6-hydroxytropinone was dissolved in 1.5L of dichloromethane. 300g of dimethoxymethane was added, mixed evenly, 100g of p-toluenesulfonic acid was added, and the reaction was carried out at 50°C for 24 hours. After the reaction, the solution was cooled to below 10°C, and sodium carbonate solution was added dropwise until the solution was alkaline. The organic phase was separated and the organic solvent was removed by vacuum distillation to obtain 443g of 6-methoxymethoxytropinone. 6-methoxymethoxytropinone was dissolved in 95% ethanol, 30g of Raney nickel was added as a catalyst, hydrogen was charged to 194Kpa, and the mixture was shaken at room temperature for 8h, filtered, and the filtrate was concentrated to obtain 426g of 6-methoxymethoxytropinol.

[0055] Step 4, 426g 6-methoxymethoxy tropinol and 520g L-tropic acid are esterified in 120g acidic strong cation exchange resin as catalyst and 100ml acetone as solvent (80°C, 4h), and after the reaction is completed, it is hydrolyzed in 2500ml of 5% hydrochloric acid solution for 6 hours to obtain anisodamine hydrochloric acid solution. The anisodamine hydrochloric acid solution is adjusted to pH 9.0-10.0, extracted with 1 times dichloromethane 4 times to obtain anisodamine extract. The anisodamine extract is concentrated under reduced pressure at 65°C to obtain 1.10kg of anisodamine crude product, dissolved in 2.2L of anhydrous ethanol, and hydrobromic acid solution (620ml) is added dropwise to pH 2-4, crystallized at 5-10°C for 12h, filtered, and the filter cake is dried at 80°C to obtain 1.02kg of anisodamine hydrobromide crude product. 1.02 kg of crude anisodamine hydrobromide was added with 6 L of anhydrous ethanol and dissolved under reflux at 75°C, crystallized by the same method (i.e., adding hydrobromic acid to pH 2-4, crystallizing at 5-10°C for 12 hours), dried and crushed to obtain 792 g of anisodamine hydrobromide. The yield was 58.8% based on 6-hydroxytropinone, and the chromatographic purity was 99.8%.

[0056] Test Example 1 Quality Analysis of the Injection Prepared by Anisodamine Hydrobromide Prepared by the Present Invention

[0057] 1 Materials

[0058] 1.1 Drugs and reagents

[0059] Anisodamine hydrobromide prepared according to Example 1; anisodamine hydrobromide reference substance (Chengdu No. 1 Pharmaceutical Co., Ltd., batch number 20901DZ, purity 99.1%); racemic anisodamine reference substance (China Food and Drug Inspection Institute), acetonitrile was chromatographically pure (TEDIA, USA), phosphoric acid and potassium dihydrogen phosphate (Chengdu Kelong Chemical Reagent Co., Ltd.) were analytically pure.

[0060] 1.2 Instruments

[0061] LC-2030 high performance liquid chromatograph (Shimadzu Corporation, Japan); Welch Ultimate AQ-C18 chromatographic column (4.6×250 mm, 5 μm); FE28 pH meter (Mettler-Toledo, Switzerland).

[0062] 2 Methods and Results

[0063] 2.1. Sterilization process

[0064] Take the anisodamine hydrobromide prepared according to Example 1, dissolve it in water for injection, and sterilize it repeatedly at 121° C. The sterilization time is 0 min, 15 min, and 30 min, respectively, and detect the isomer content in the prepared anisodamine hydrobromide injection. The specific method is as follows:

[0065] S1. Take the anisodamine hydrobromide prepared in Example 1, add water to dissolve it, and sterilize it at 121° C. to obtain a sterilized anisodamine hydrobromide solution; remove the anisodamine reference substance, and add water to prepare a reference substance solution;

[0066] S2. The anisodamine hydrobromide solution and the reference substance solution obtained in step S1 are detected by high performance liquid chromatography, and the chromatographic conditions of the high performance liquid chromatography are:

[0067] Octadecylsilane bonded silica gel is used as filler;

[0068] Acetonitrile-50mmol / L dipotassium hydrogen phosphate solution (the pH of the dipotassium hydrogen phosphate solution was adjusted to 6.0 with phosphoric acid) in a volume ratio of 10:90 was used as mobile phase A; acetonitrile-50mmol / L dipotassium hydrogen phosphate solution (the pH of the dipotassium hydrogen phosphate solution was adjusted to 6.0 with phosphoric acid) in a volume ratio of 45:55 was used as mobile phase B;

[0069] The elution gradient is:

[0070]

[0071]

[0072] The column temperature was 30°C; the detection wavelength was 210 nm;

[0073] The injection volume was 20 μl and the flow rate was 1.0 ml / min;

[0074] S3. Compare the chromatogram of the anisodamine hydrobromide solution described in step S2 with the chromatogram of the reference solution, and present a chromatographic peak in the chromatogram of the anisodamine hydrobromide solution with a retention time consistent with that of the isomer in the chromatogram of the reference solution, to determine that the anisodamine hydrobromide solution contains isomers, and the generation rate of the isomers is calculated as the ratio of the peak area of ​​the isomer in the chromatogram of the anisodamine hydrobromide solution to the sum of the areas of all chromatographic peaks.

[0075] The result is that the unknown impurity peak in the scopolamine hydrobromide injection at about 12 minutes has the same retention time as the diastereoisomer peak in the racemic scopolamine peak. Figures 1-2 As shown: The detection method for 0h and 15min is the same as the above detection method, and the results are as follows:

[0076] Sterilization time 0h 15min 30min batch number 21122901 21122901-A 21122901-B Isomer % 0% 0.6% 1.87%

[0077] Therefore, it can be concluded that when the sterilization time is less than 15 minutes, the quality of scopolamine hydrobromide can be guaranteed and the impurity limit is within the prescribed range of the "Chinese Pharmacopoeia". If it exceeds 15 minutes, a large amount of impurities will be produced.

[0078] In order to confirm the specific structure of the impurities produced, the following structural confirmation was performed:

[0079] 2.2. Structural confirmation

[0080] Take the sterilized 30 minutes of scopolamine hydrobromide injection, chromatograph on LD-2 column (filler is C18 silica gel), and separate the isomeric impurities by eluting with 0.1% formic acid-methanol washing system. Use conventional elution method to collect the second elution chromatographic peak, concentrate and extract, and concentrate under reduced pressure to obtain the isomer.

[0081] Mass spectrometry

[0082] The separated isomers were sent to Chengdu Ruizhi Chemical for mass spectrometry. The molecular weights were 306.2 (main peak) and 306.4 (secondary peak), which were consistent with the molecular weight of anisodamine. See Table 1 and Table 2 for details. Figure 3 shown.

[0083] Table 1 Isomer mass spectrometry information

[0084]

[0085]

[0086] 2.2.2. Hydrogen spectrum detection

[0087] Testing unit: Chengdu Ruizhi Chemical Research Co., Ltd.;

[0088] Test items: 1 H-NMR

[0089] Instrument: BrukerAVⅡ-400MHz NMR spectrometer;

[0090] Test basis: General Rules 0441 Nuclear Magnetic Resonance Spectroscopy of Part IV of the Pharmacopoeia of the People's Republic of China 2020 Edition

[0091] The separated isomers were sent to Chengdu Ruizhi Chemical for nuclear magnetic resonance hydrogen spectrum detection. The results were consistent with the structure of scopolamine. See Table 2 and Figure 4 As shown, the structural formula is as follows:

[0092]

[0093] Table 2 Hydrogen spectrum detection results

[0094] Proton number Chemical shift (ppm) Number of protons Remark 1 3.894 1H,d <![CDATA[CH 2 -CH-(C) 2 ]]> 2,4,7 1.805~2.306 2H,m <![CDATA[CH-CH 2 -CH]]> 3 4.695~4.955 1H,t <![CDATA[O-CH-(CH 2 ) 2 ]]> 5 3.689 1H,s <![CDATA[N-CH 2 -(CH 2 ) 2 ]]> 6 4.406 1H,m <![CDATA[N-CH 2 -(CH 2 ) 2 ]]> 9 2.863 3H,s <![CDATA[N-CH 3 ]]> 12 3.689~3.935 2H,t <![CDATA[HO-CH 2 -CH]]> 13 4.102~4.406 1H,m <![CDATA[HO-CH-(CHCH 2 )]]> 16-20 7.310-7.394 5H,m Hydrogen on benzene ring

[0095] The multiple peaks at δ7.310-7.394ppm, with 5 hydrogens, should all be hydrogens on the benzene ring.

[0096] The triplet peak at δ4.695-4.955 ppm, with two hydrogens, should be the methine hydrogens directly affected by the carboxyl group;

[0097] The doublet peak at δ3.894ppm should be the methine hydrogen directly affected by the carboxyl group and the benzene ring;

[0098] The multiple peaks at δ4.116-4.169 ppm, with one hydrogen, should be the methylene hydrogen peak on 16-C.

[0099] The triplet peak at δ3.689~3.935ppm, 2 hydrogens, should be two methylene peaks directly connected to the hydroxyl group

[0100] The multiple peak at δ4.406ppm, with one hydrogen, should be the peak of the methine hydrogen that is severely affected by the amino cation.

[0101] The single peak at δ3.689 ppm should be the methylene hydrogen of carbon 1.

[0102] The single peak at δ2.863 ppm should be the three methyl hydrogens on the amine methyl group.

[0103] The multiple peaks of δ1.805~2.306, with a total of 6 hydrogens, should be the three methylene peaks on the seven-membered ring affected by the electron-withdrawing effect of the tertiary amine.

[0104] Conclusion: Pass 1 It can be seen from the H-NMR test data table that the sample hydrogen spectrum is consistent with the molecular structure characteristics of scopolamine hydrobromide.

[0105] The carbon spectrum data are shown in Table 3 and Figure 5 As shown:

[0106]

[0107] Table 3 13 C-NMR Test Data Sheet

[0108]

[0109] Analysis:

[0110] The molecular formula of anisodamine hydrobromide is C 17 H 23 NO 4 HBr, the molecule contains 17 carbon atoms, but the nitrogen and methyl carbon atoms do not show any peaks.

[0111] The carbon atom at δ172.67ppm corresponds to the peak of the carboxyl carbon in the molecular structure of anisodamine hydrobromide;

[0112] The carbon atoms at δ128.29-135.24 ppm correspond to the peaks of the benzene ring carbon in the molecular structure of anisodamine hydrobromide;

[0113] The carbon atom at δ135.24 ppm is the peak of the quaternary carbon on the benzene ring;

[0114] δ32.63ppm, δ33.65ppm, and δ34.77ppm are the peaks of secondary carbon on the tropine ring;

[0115] δ63.09ppm is the peak of secondary carbon on hydroxymethyl;

[0116] The methyl carbon atom on nitrogen does not produce a peak;

[0117] The carbon numbers 5-14 in the table correspond to the peaks of other alkyl carbons in the molecular structure of anisodamine hydrobromide;

[0118] Conclusion: The hydrogen spectrum and carbon spectrum of the sample are consistent and consistent with the molecular structure of scopolamine hydrobromide.

[0119] 2.2.3. Single crystal cultivation

[0120] The separated isomers were tested as follows:

[0121] Testing unit: Sichuan University Analysis and Testing Center

[0122] Instrument model: Xcalibur E CCD X-ray single crystal diffractometer

[0123] Detection method: Carefully select the test crystals of appropriate size under a microscope, fix them on the top of the capillary glass wire, and place them on the instrument sample stage for testing.

[0124] Test conditions: temperature 20℃, test power 40KW, molybdenum target, test time 3h.

[0125] The testing software was CrysAlisPro171.34, the crystal structure was analyzed using ShelXS in Olex2 software, and the crystal structure was refined using ShelXL in Olex2 software based on the least squares method.

[0126] The crystal structure was analyzed by ShelXS in Olex2 software, and the structure was solved by direct method. The crystal structure was refined by ShelXL in Olex2 software based on the least squares method.

[0127] (1) Results

[0128] Chemical formula: C 17 H 24 BrNO molecular weight (386.28), orthorhombic system, space group P2 1 2 1 2 1 (Space group number: 19).

[0129] The unit cell parameters are: The unit cell volume is Each unit cell contains 4 molecules.

[0130] The test temperature is 293.15K, the molybdenum target (wavelength is 2.289mm -1 ), the theoretical density is 1.417 g / cm 3 A total of 5928 diffraction points were collected in the range of (6.206°≤2Θ≤52.732°), of which 3243 independent diffraction points were obtained in the range of (Rint=0.0304, Rsigma=0.0608) for complete calculation. The final R1 (residual factor) value was 0.0433 (I>2σ(I)), and the wR2 (weighted residual factor) value was 0.0795.

[0131] (2) Conclusion

[0132] The single crystal diffraction results of specific hydrobromic acid isomers are as follows Figure 6 As shown in the results, it is 6S, 2'R configuration. From the configuration of the impurity, it can be concluded that the structure obtained by the preparation method of the present invention is anisodamine hydrobromide. Due to high temperature sterilization, an optical isomer 6S, 2'R configuration is produced, which is different from the single configuration of 6S, 2S of 654-1 itself.

[0133] 2.3 Quality comparison of scopolamine hydrobromide injection

[0134] The injection (batch number 21122901) prepared with the anisodamine hydrobromide obtained in Example 1 of the present invention as a raw material and the injection prepared with the commercially available anisodamine hydrobromide as a raw material according to the same process were subjected to liquid chromatography detection, and the chromatographic conditions were the same as those in "2.1 Sterilization Process". The test results are shown in Figure 7-Figure 8 From the test results, it can be seen that the injection prepared by using the anisodamine hydrobromide of the present invention has a lower content of isomers and better quality.

[0135] 3 Discussions

[0136] 3.1. Control of isomers in Anisodamine Hydrobromide Injection

[0137] Anisodamine hydrobromide injection may only produce one isomeric impurity - 6S, 2'R configuration during production and stability study. The main condition for its generation is high temperature destruction, so proper control of sterilization parameters and storage conditions has a certain effect on the control of isomeric impurities. At present, only 6S, 2'R isomers are detected in the injection, thus proving that what is obtained in Example 1 is anisodamine hydrobromide.

[0138] 3.2. Discussion of pharmacological activity

[0139] According to the literature, anisodamine has stereoselective relaxation effect on isolated rat trachea. The activities of the four isomers are: (6S, 2'S) > (6S, 2'R) > (6R, 2'S) > (6R, 2'R), indicating that the S configuration on the scopolamine mother nucleus of anisodamine plays an important role in anticholinergic activity. The anisodamine hydrobromide of the present invention is a single compound of 6S, 2'S configuration, and therefore has stronger activity than racemic anisodamine.

[0140] 3.3. Toxicological discussion

[0141] Studies have reported that single-configuration natural scopolamine has a slightly stronger antispasmodic effect on smooth muscle, while the synthetic product of the four isomers has a slightly stronger effect on anti-tremorine analgesia, mydriasis and inhibition of saliva secretion. The synthetic product has a slightly higher median lethal dose in mice. The dose is also slightly higher in the treatment of Meniere's syndrome and sudden deafness. The [3H]-QNB ligand receptor binding experiment, the anti-acetylcholine effect on the contraction of guinea pig ileal longitudinal muscle strips, and the anti-pilocarpine salivation and mydriasis effects were used as indicators to compare the interaction effect strength of the four isomers of scopolamine with the M cholinergic receptor. The results of this experiment show that the four isomers of anisodamine have significantly different effects on the relaxation of isolated rat trachea: This result further confirms that the S configuration on the tropane nucleus of scopolamine plays an important role in binding to the M receptor.

[0142] This indirectly indicates that scopolamine hydrobromide is less toxic than synthetic racemic scopolamine.

[0143] 3.4. Comparison of racemic anisodamine and anisodamine hydrobromide

[0144] When preparing injections from raw materials with the same impurity level, racemic anisodamine itself contains four configurations, so during the production of preparations, configuration changes may occur, resulting in configuration differences and changes in toxic and side effects. Anisodamine hydrobromide is a compound with a single configuration, which is relatively stable during production, is not easy to produce toxic and side-effect impurities, and is also conducive to quality control.

[0145] In summary, the method of the present invention has a high conversion rate, reduces the cost, and improves the difficulty of purifying scopolamine hydrobromide. The obtained scopolamine hydrobromide product contains no isomers, has high product purity, improves quality, and has broad market application prospects.

Claims

1. A method for preparing anisodamine hydrobromide, characterized in that: It includes the following steps: a. Preparation of L- tropic acid: Take a datura flower extract, add water and ES-PLE-101 type lipase to hydrolyze, then extract with an organic solvent, remove the organic solvent from the extract, add acid water to adjust the pH to acidic, crystallize, and obtain L- tropic acid; The datura flower extract is obtained by dissolving the ethanol extract of datura flower in 5% sulfuric acid, filtering and removing insoluble matter through water precipitation, and then concentrating to obtain a thick paste with a relative density of 1.8 to 2.4; b. Preparation of 6-methoxymethoxy tropinol: 6-hydroxy tropinone and dimethoxymethane are mixed and reacted, the obtained reactant is cooled to below 10°C, sodium carbonate solution is added until the pH is alkaline, the organic phase is removed from the organic solvent, 95% ethanol is added to dissolve, a catalyst is added, hydrogen is passed through for hydrogenation, and 6-methoxymethoxy tropinol is obtained by filtration and concentration; The structural formula of the 6-hydroxytropinone is as follows: ; c. Preparation of scopolamine hydrobromide: 6-methoxymethoxytropine obtained in step b and L-tropic acid obtained in step a are mixed, a catalyst is added to react, the obtained reactant is hydrolyzed with hydrochloric acid, the pH of the hydrolyzate is adjusted to alkaline, an organic solvent is added for extraction, and the extract is concentrated to obtain a crude anisodamine product, the crude anisodamine product is dissolved in anhydrous ethanol, hydrobromic acid is added to pH 2 to 4, crystallized, filtered, and the crystals are recrystallized to obtain.

2. The preparation method according to claim 1, characterized in that: The mass volume ratio of the datura flower extract, water, ES-PLE-101 type lipase and organic solvent in step a is 1000g:5000-40000ml:0.1-10g:5000-40000ml.

3. The preparation method according to claim 2, characterized in that: The organic solvent is dichloromethane, chloroform or ethyl acetate.

4. The preparation method according to claim 1, characterized in that: In step a, the acid water is a 5% sulfuric acid solution; the pH is adjusted to 3-4; and the crystallization temperature is 5°C.

5. The preparation method according to claim 1, characterized in that: In step b, the mass ratio of the 6-hydroxytropinone to the dimethoxymethane is 1:0.5-2; the reaction conditions are: p-toluenesulfonic acid as a catalyst, dichloromethane as a reaction solvent, and reflux reaction at 30-60° C. for 12-36 hours; The added catalyst is Raney nickel; The mixture was passed with hydrogen to 204 KPa and shaken at room temperature for 8 h.

6. The preparation method according to claim 1, characterized in that: In step c, the mass ratio of the 6-methoxymethoxy tropine alcohol to the L-tropine acid is 1:0.8-1.6; the catalyst is an acidic strong cation exchange resin; the reaction conditions are acetone as a solvent, and the reaction is carried out at 40-60° C. for 4-8 hours; The hydrolysis temperature is 60-80°C, and the time is 4-8 hours; the concentration of the hydrochloric acid is 5%, v / v, and the amount used is 2-3 times the sum of the 6-methoxymethoxytropine alcohol and the L-tropine acid, ml / g; The pH of the hydrolyzate is adjusted to 9.0-10.0; The organic solvent is dichloromethane, and the amount used is 1 times the amount of the hydrolyzate, ml / ml; The mass volume ratio of the crude anisodamine to anhydrous ethanol is 1-2 g:1-5 ml; the concentration of the hydrobromic acid is 10%, v / v.